NCT06243757Active, not recruiting
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
Source: ClinicalTrials.gov · Last updated 22 Jul 2026
Brief summary (registry, in English)
Participants will a diagnosis of gastroesophageal junction (GEJ) adenocarcinoma and will have either a minimally invasive proximal gastrectomy (MIPG) or a minimally invasive total gastrectomy (MITG) as part of their routine care. Participants with complete a questionnaire 1 month before the surgical procedure and then 1, 3, 6 and 12 months after the surgical procedure.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 4 (actual)
- First submitted
- 29 Jan 2024
- Start date
- Jan 2024
- Primary completion date
- Jan 2036
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06243757
What you commit to
- Study type: Observational
- Participants enrolled: 4
- From Jan 2024 to the primary completion date, Jan 2036
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)
Other illness
- Patients with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
Other
- Patients with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent
- Subjects deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
Who the study is looking for
- Able to speak and read English, Spanish, Japanese or Korean
- Patients with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
- Age ≥ 18
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Coordinator of this site? Confirm its status | Basking Ridge | United States | Unknown status |
| Memorial Sloan Kettering Commack (All protocol activities) Coordinator of this site? Confirm its status | Commack | United States | Unknown status |
| Memorial Sloan Kettering Westchester (All Protocol Activities) Coordinator of this site? Confirm its status | Harrison | United States | Unknown status |
| MD Anderson Cancer Center (Data Analysis Only) Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) Coordinator of this site? Confirm its status | Middletown | United States | Unknown status |
| Memorial Sloan Kettering Bergen (All Protocol Activities) Coordinator of this site? Confirm its status | Montvale | United States | Unknown status |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Memorial Sloan Kettering Nassau (Limited Protocol Activites) Coordinator of this site? Confirm its status | Rockville Centre | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.